In view of these early results in colorectal cancer cells, the combined use of RSV with one of these pharmacological inhibitors of MDR or MRP would counteract the low bioavailability of polyphenol and increase its effectiveness. This evidence concerns the gene ABCC1 and colorectal cancer.